Biometrische Planung von klinischen Prüfungen, bei denen eine überlegene Wirksamkeit nur in einer Subgruppe zu erwarten ist. - Meinhard Kieser; Jochem König; Norbert Victor (GMDS, 1994)

Configural frequency analysis and association analyses in contingency tables. - Norbert Victor; Meinhard Kieser (Comput. Stat. Data Anal., 2003)

Including long- and short-term data in blinded sample size recalculation for binary endpoints. - Kirsten Wüst; Meinhard Kieser (Comput. Stat. Data Anal., 2005)

Leveraging Markov Models to Compute Prevalence Estimates for a Regional Breast Cancer Registry. - Monika Pobiruchin; Meinhard Kieser; Wendelin Schramm (ICIMTH, 2013)

An expected power approach for the assessment of composite endpoints and their components. - Géraldine Rauch; Meinhard Kieser (Comput. Stat. Data Anal., 2013)

Sample Size Calculation and Blinded Sample Size Recalculation in Clinical Trials Where the Treatment Effect is Measured by the Relative Risk. - Monika Pobiruchin; Meinhard Kieser (Commun. Stat. Simul. Comput., 2013)

Consistency-adjusted alpha allocation methods for a time-to-event analysis of composite endpoints. - Géraldine Rauch; Marius Wirths; Meinhard Kieser (Comput. Stat. Data Anal., 2014)

A method for using real world data in breast cancer modeling. - Monika Pobiruchin; Sylvia Bochum; Uwe M. Martens; Meinhard Kieser; Wendelin Schramm (J. Biomed. Informatics, 2016)

The adoptr Package: Adaptive Optimal Designs for Clinical Trials in R. - Kevin Kunzmann; Maximilian Pilz; Carolin Herrmann; Géraldine Rauch; Meinhard Kieser (J. Stat. Softw., 2021)

blindrecalc - An R Package for Blinded Sample Size Recalculation. - Lukas Baumann; Maximilian Pilz; Meinhard Kieser (R J., 2022)

drugdevelopR: Planning of phase II/III drug development programs with optimal sample size allocation and Go/No-go decision rules in R. - Johannes Cepicka; Lukas D. Sauer; Marietta Kirchner; Meinhard Kieser; Stella Erdmann (SoftwareX, 2025)